NCT03848091

Brief Summary

One-step exchange arthroplasty is more and more used in the treatment of chronic infections, especially in patients at risk anesthetic. This strategy is not recommended in patients infected with multidrug-resistant organisms or difficult to treat because of a risk of bacterial persistence on the new implant. Antibiotic pretreatment by a narrow-spectrum molecule and for which resistance acquisition is difficult might be of interest to try to reduce the inoculum and avoid contamination of the new implant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 20, 2019

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

1.8 years

First QC Date

February 19, 2019

Last Update Submit

February 27, 2024

Conditions

Keywords

bone and joint infectionAntibiotic pretreatment

Outcome Measures

Primary Outcomes (1)

  • Rate of Treatment Failure

    Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin

    Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

Secondary Outcomes (2)

  • rate of use of this strategy

    Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

  • rate of bacteria responsible for infection

    Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

Study Arms (1)

Antibiotic pretreatment

patients having had an antibiotic pretreatment before a one-step exchange arthroplasty

Other: Antibiotic pretreatment

Interventions

a strategy with antibiotic pretreatment before one-step exchange arthroplasty in patients who bacteria responsible for the infection has been indentified (puncture, blood cultures,...)

Antibiotic pretreatment

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients having had a antibiotic pretreatment targeted before a one step exchange arthroplasty managed at the Croix-Rousse Hospital

You may qualify if:

  • patients having had a antibiotic pretreatment targeted before a one step exchange arthroplasty

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Lyon, 69004, France

Location

Study Officials

  • Tristan Ferry, Md,PhD

    HCL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CRA

Study Record Dates

First Submitted

February 19, 2019

First Posted

February 20, 2019

Study Start

April 1, 2016

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

February 28, 2024

Record last verified: 2024-02

Locations